000			01376 a2200373 4500
005			20250513225300.0
264		0	_c20010712
008			200107s 0 0 eng d
022			_a1523-3790
024	7		_a10.1007/s11912-000-0061-5 _2doi
040			_aNLM _beng _cNLM
100	1		_aNanus, D M
245	0	0	_aNew treatment approaches for metastatic renal cell carcinoma. _h[electronic resource]
260			_bCurrent oncology reports _cSep 2000
300			_a417-22 p. _bdigital
500			_aPublication Type: Journal Article; Review
650	0	4	_aAntibodies, Monoclonal _xtherapeutic use
650	0	4	_aAntineoplastic Agents _xtherapeutic use
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use
650	0	4	_aBone Marrow Transplantation
650	0	4	_aCancer Vaccines
650	0	4	_aCarcinoma, Renal Cell _xdrug therapy
650	0	4	_aChemotherapy, Adjuvant
650	0	4	_aClinical Trials as Topic
650	0	4	_aDisease-Free Survival
650	0	4	_aHumans
650	0	4	_aInterferon-alpha _xtherapeutic use
650	0	4	_aInterleukin-2 _xtherapeutic use
650	0	4	_aKidney Neoplasms _xdrug therapy
650	0	4	_aPrognosis
650	0	4	_aT-Lymphocytes _ximmunology
773	0		_tCurrent oncology reports _gvol. 2 _gno. 5 _gp. 417-22
856	4	0	_uhttps://doi.org/10.1007/s11912-000-0061-5 _zAvailable from publisher's website
999			_c11063372 _d11063372